H. Lee Moffitt Cancer Center and Research Institute
#18 in Institutes and Centers
18Institution Overview
Overall
Ranking
18
Rank in
Research Capabilities
Rank in
Entrepreneurial Readiness
Rank in
Market Translation
H. Lee Moffitt Cancer Center and Research Institute ranks 18th among biomedical institutes in the Cure Innovation Index, based in Tampa, Florida. Its research capabilities place it in the upper tier of its peer category; market translation and entrepreneurial readiness fall closer to the middle of the field. The center supports an incubator and accelerator, an entrepreneur-in-residence program, and clinical trials led by faculty as principal investigators. Moffitt's profile reflects a balance between foundational discovery and translational activity consistent with its standing as an NCI-designated cancer center.

Ranking Metrics
Research Capabilities
H. Lee Moffitt Cancer Center and Research Institute ranked above average for Research Capabilities, a measure of the foundational infrastructure and resources that enable an institution to conduct high-quality, innovative science. Out of the factors in this category, H. Lee Moffitt Cancer Center and Research Institute fared best in Cutting Edge Science.
Learn MoreEntrepreneurial Readiness
H. Lee Moffitt Cancer Center and Research Institute ranked below average for Entrepreneurial Readiness, a measure of whether the institution has built a supportive ecosystem for entrepreneurship and whether faculty are engaged in and incentivized toward commercial activity. Out of the factors in this category, H. Lee Moffitt Cancer Center and Research Institute fared best in Faculty Engagement.
Learn MoreMarket Translation
H. Lee Moffitt Cancer Center and Research Institute ranked above average for Market Translation, a measure of how effectively a research institution moves scientific discovery out of the lab and into real-world clinical and commercial applications. Out of the factors in this category, H. Lee Moffitt Cancer Center and Research Institute fared best in Experienced TTO.
Learn More
Cure Innovation Index Methodology
From a pool of more than 6,000 institutions, the top 303 were ranked using two dozen indicators — from scientific foundation and lab infrastructure to patents, products, and partnerships — drawn from more than a dozen federal and commercial databases, an original audit of all institutions, and surveys of more than 3,300+ scientists, industry leaders, and biomedical experts.
Insights From the Cure Innovation Index
Explore by Category
Innovation isn't a single moment — it's an entire ecosystem. The Index evaluates institutions across two dozen indicators, grouped in three core domains that reveal the full picture of what it takes to turn groundbreaking science into real-world impact.


